Dr. Samer Salamekh, MD

Dr. Salamekh practices at Cancer Specialists of North Florida in Jacksonville, Florida.

Dr. Salamekh's NPI, 1194266544, was assigned on March 18, 2017. Dr. Salamekh graduated from Ohio State College of Medicine in 2016. Dr. Salamekh holds Florida license ME155286.

Dr. Salamekh's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.

Dr. Salamekh's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Salamekh to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salamekh practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Salamekh's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Salamekh is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Salamekh's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Salamekh treats.

CMS data shows 2,444 Medicare services from Dr. Salamekh across 17 procedure codes in 2024, for 178 Medicare patients. Medicare paid $459,785 for them. Every service was in an office.

CMS counts 178 Medicare patients who saw Dr. Salamekh in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salamekh's median patient age at 70, with 50% women.

In 2024, Dr. Salamekh wrote 284 Medicare Part D claims for 106 patients. 87% of them were for generic drugs. CMS names the drug for 198 of them, across 12 drugs with 11 or more claims each, at $2,779 in total drug cost. In 2023, CMS named 48 claims across 4 drugs.

Dr. Salamekh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Salamekh, published from 2011 to 2023. 2011 was the busiest year, with 3. The most frequent topics are Islet Amyloid Polypeptide, Adenocarcinoma and Amino Acid Sequence. Dr. Salamekh's most frequent co-authors are Sujana Gottumukkala, MD, Nina Niu Sanford, MD and Kevin V. Albuquerque, MD.

CMS Open Payments shows 22 general payments to Dr. Salamekh from 12 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,070.

Dr. Salamekh graduated from Ohio State College of Medicine in 2016.

Dr. Salamekh is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.